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expression was significantly higher in old than in young 
mice, except for  Mct8 and  Oatp1a1  expression levels . Hyper-
thyroidism resulted in upregulation of  Mct10 ,  Lat1 and  Lat2 
in liver tissue, while  Oatp1a1 ,  Oatp1b2 and  Oatp1a4  expres-
sion was downregulated. This effect was preserved in old 
animals.  Conclusion: Here, we show age-dependent differ-
ences in TH transporter mRNA expression in the euthyroid 
and hyperthyroid state of mice focusing on the liver as a clas-
sical TH target organ.  © 2015 European Thyroid Association
Published by S. Karger AG, Basel 
 Introduction 
 Hyperthyroidism is a pathological state characterized 
by excessive thyroid hormone (TH) action in the body. 
Classical clinical features include anxiety, nervousness, 
tremor, weight loss and heat intolerance, which are often 
obscured in elderly patients and hence diagnosis may be 
missed  [1] . Hyperthyroidism is associated with signifi-
cant morbidity and mortality, mainly from cardiovascu-
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 Abstract 
 Background: Clinical features of thyroid dysfunction vary 
with age, and an oligosymptomatic presentation of hyper-
thyroidism is frequently observed in the elderly. This sug-
gests age modulation of thyroid hormone (TH) action, which 
may occur, for example, by alterations in TH production, me-
tabolism and/or TH action in target organs.  Objectives: In 
this paper, we address possible changes in TH transporter 
expression in liver tissues as a mechanism of age-dependent 
variation in TH action.  Methods: Chronic hyperthyroidism 
was induced in 4- and 20-month-old C57BL6/NTac male 
mice (n = 8–10) by intraperitoneal injections of 1 μg/g body 
weight  L -thyroxine (T 4 ) every 48 h over 7 weeks. Control ani-
mals were injected with PBS. Total RNA was isolated from 
liver samples for analysis of the TH transporter and TH-re-
sponsive gene expression. TH concentrations were deter-
mined in mice sera.  Results: Baseline serum free T 4 (fT 4 ) con-
centrations were significantly higher in euthyroid young 
compared to old mice. T 4 treatment increased total T 4 , fT 4 
and free triiodothyronine to comparable concentrations in 
young and old mice. In the euthyroid state, TH transporter 
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lar and cerebrovascular disease, which are conditions that 
are particularly relevant to an aging population  [2–4] .
 It is widely accepted that circulating TH levels may not 
solely and comprehensively reflect TH organ status. In 
fact, TH action is complex and, in addition to different 
TH derivatives, involves distinct transmembrane trans-
porters and nongenomic versus classical nuclear modes 
of TH action, all of which may be altered with age. How-
ever, their variations upon aging have not been thorough-
ly analyzed, neither in humans nor in mice. 
 Animal models serve as useful tools to dissect mech-
anisms of TH action. In this study, we aimed to investi-
gate whether age may result in alterations of proposed
TH transporters in liver as a classical TH target organ. To 
this aim, young (4 months) versus aged (20 months) 
C57BL/6NTac male mice were studied under conditions 
of euthyroidism and chronic hyperthyroidism. In addi-
tion to serum concentrations, total thyroxine (TT 4 ), free 
thyroxine (fT 4 ) and free triiodothyronine (fT 3 ), TH trans-
porter mRNA levels and expression of TH-responsive 
genes were determined in liver tissues of euthyroid and 
hyperthyroid young and old mice.
 Materials and Methods 
 Animals 
 Male C57BL/6NTac (Taconic Europe A/S, Denmark, and 
Taconic Biosciences Inc., USA) mice (n = 32) aged 4 months 
(young) and 20 months (old) were housed in temperature- (23 ± 
1   °   C) and light-controlled (inverse 12: 12-hour light-dark cycle) 
conditions. Food and water were provided ad libitum. All animal 
experiments were performed in accordance with the German Reg-
ulations for Laboratory Animal Science (GVSOLAS) and the Eu-
ropean Health Law of the Federation of Laboratory Animal Sci-
ence Associations (FELASA). The protocols for animal studies 
were approved by the Landesamt für Natur, Umwelt und Ver-
braucherschutz Nordrhein-Westfalen (LANUV-NRW), Germany.
 Treatment 
 For induction of a chronic hyperthyroid state, animals received 
freshly prepared intraperitoneal (i.p.) injections of 1 μg/g body 
weight (BW) T 4 [Sigma-Aldrich, USA; stock-solution: 2 mg/ml in 
0.01  M NaOH, 0.1% BSA (albumin from bovine serum, Sigma-
Aldrich); injection solution: stock solution diluted 1: 10 with PBS] 
every other day. Control groups received 150 μl PBS i.p. every oth-
er day. The treatment period was 7 weeks.
 Blood Sample Collection and TH Measurements 
 Blood samples were collected from the retrobulbar venous 
plexus with a heparinized micropipette at the start of experiment 
and after 5 weeks of T 4 treatment (48 h after the last T 4 injection) 
from each animal. Blood samples were stored on ice for 30 min for 
coagulation and serum was obtained by centrifugation at 4   °   C for 
10 min at 10,000  g . Serum aliquots were stored at –80  °  C. TT 4 , fT 3 
and fT 4 concentrations in serum of mice were measured using 
commercial ELISA kits according to the manufacturer’s instruc-
tions (DRG Instruments GmbH, Germany). As standards, serum 
samples with known TH concentrations were used.
 Collection of Mice Livers 
 For liver collection, mice were perfused with heparinized saline 
through a needle placed in the left ventricle. Livers were isolated 
quickly, frozen in liquid nitrogen and stored at –80  °  C until further 
processing.
 Isolation of RNA  
 For RNA extraction, tissues were homogenized in 600 μl of 
RLT buffer (Qiagen, Germany) using a tissue homogenizer UL-
TRA-TURRAX ® T25 at 4,000 rpm (Janke & Kunkel IKA, Ger-
many). The tissue lysates were further treated with proteinase K 
(Qiagen) based on the manufacturers’ protocol. Total RNA from 
liver tissue lysates was purified by using the RNeasy Mini Kit and 
further by on-column DNase digestion using the RNase-Free 
DNase Set (Qiagen). RNA quantity and quality were determined 
using NanoDrop 1000 (Thermo Scientific), and the integrity of 
RNA was further assessed via gel electrophoresis followed by 
ethidium bromide staining to visualize 28S and  18S rRNA. 
 Synthesis of cDNA and Real-Time PCR 
 2 μg of RNA was reverse transcribed to cDNA using random 
hexamers and SuperScript III First-Strand Synthesis System for 
real-time PCR according to the instruction manuals (Life Tech-
nologies, Germany). Exon-spanning primers for amplification of 
TH responsive genes (online suppl. table 1; for suppl. material, see 
www.karger.com/doi/10.1159/000381020) were designed using 
PrimerBlast (NCBI) and synthesized by Eurofins (Eurofins MWG 
Synthesis, Germany). Quantitative real-time PCR was performed 
using LightCycler ® DNA Master SYBR Green I and the LightCy-
cler ® 480 System (Roche, Germany). The PCR program consisted 
of an initial denaturation step (5 min at 95  °  C) and 40 amplification 
cycles with 15 s at 95   °   C, 10 s at 60   °   C and 20 s at 72   °   C. Melting 
curve analysis was performed after each PCR, and PCR products 
were verified by agarose gel electrophoresis.
 For normalization of gene expression, the reference genes  18S , 
 Ppia (peptidylprolyl isomerase A, cyclophilin A) and Rpl13a  (ribo-
somal protein L13a) were used. The stability of the housekeeping 
genes was determined by calculation of the coefficient of variation 
on the normalized relative quantities and by calculation of the ge-
Norm M value  [5] . The geometric average of the ‘best’ three house-
keeping genes (best keeper index) was calculated by repeated pair-
wise correlation analysis  [5] . Fold changes were calculated by the 
Relative Expression Software Tool (REST © , efficiency-corrected 
ΔΔCt method)  [6, 7] .
 Statistical Analysis 
 All data are shown as means ± SD or standard error of the mean 
(SEM), as indicated. Statistical analysis was performed using the 
unpaired Student’s t test of GraphPad Prism 5 Software. For statis-
tical analysis of real-time PCR results (in figures presented as log-
arithmic fold-change data) antilogarithmic data of T 4 -treated mice 
were compared to antilogarithmic data of PBS-treated controls 
(variations within the control groups are not shown). Values of
 *  p < 0.05,  * *  p < 0.01,  * * *  p < 0.001 and  #  p < 0.0001 were consid-
ered statistically significant.
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 Results 
 Effect of T 4 Administration and Aging on TT 4 , fT 4 and 
fT 3 Serum Concentrations in Mice 
 To examine TH serum changes with T 4 administration 
over the experimental time period, retro-orbital blood 
samples were collected at the beginning of and during T 4 
treatment.
 Under T 4 treatment, young and old male mice dis-
played an up to 4- to 6-fold increase in TT 4 (p < 0.0001 in 
young and p < 0.05 in old male mice) and a 2- to 4-fold 
increase in fT 4 (p < 0.0001 in young and p < 0.05 in old 
male mice) serum concentrations, respectively. In addi-
tion, small but significant increases of serum fT 3 concen-
trations (p < 0.01 in young and p < 0.05 in old male mice) 
were measured under T 4 treatment ( fig. 1 ).
 In the control animals, age differences in TH serum 
concentrations were observed for fT 4 values, which were 
2-fold higher in young compared to old male mice (p < 
0.0001;  fig. 1 b). In contrast, TT 4 as well as fT 3 concentra-
tions remained unchanged with aging ( fig. 1 a, c).
 Effect of Aging on TH Transporter Expression in Liver 
 To examine the impact of aging on TH transporter 
expression, fold changes of TH transporter expression 
levels in old liver were compared to young liver tissues 
for euthyroid (control) animals. We found an increased 
expression of most TH transporters with aging in livers 
of euthyroid mice. Thus, old control animals showed a 
significantly higher expression of  Mct10 ,  Lat2 ,  Oatp1b2 
and  Ntcp (p < 0.05;  fig. 2 ) as well as of  Lat1 and  Oatp1a4 
(p < 0.01;  fig. 2 ) in liver tissues compared to young mice. 
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 Fig. 1. Serum levels of TH in euthyroid and T 4 -treated young and 
old male mice. TT 4 ( a ), fT 4 ( b ) and fT 3 ( c ) were determined in sera 
by ELISA at the start and after 5 weeks of T 4 treatment (1 μg/g BW 
T 4 i.p. every 48 h). A significant increase of TT 4 , fT 4 and fT 3 serum 
parameters was found in T 4 -treated young (4 months) and old 
(20 months) mice as compared to the euthyroid start group. The 
euthyroid control groups of young and old mice showed stable TH 
serum parameters throughout the experiments. Euthyroid old 
mice have significantly lower fT 4 values than euthyroid young 
mice. Data are presented as means ± SD; n = 16 animals for start, 
n = 8 animals (PBS-treated control) and n = 8 animals (hyperthy-
roid) for end groups; t test,  *  p < 0.05,  * *  p < 0.01,  #  p < 0.0001. 
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 Fig. 2. Effect of aging on TH transporter mRNA expression in liv-
er tissues of old compared to young euthyroid male mice. Gene 
expression levels were determined by quantitative real-time PCR 
in livers of old euthyroid mice (21.8 months) and were normalized 
to respective expression levels in livers of euthyroid young mice 
(5.8 months).  Mct10 ,  Lat1 ,  Lat2 ,  Oatp1b2 ,  Oatp1a4 and  Ntcp 
mRNA expression levels are significantly upregulated in liver tis-
sues of old mice compared to young animals.  18S ,  Ppia and Rpl13a 
were used as reference genes. Data are presented as fold changes, 
means ± SEM; n = 7; efficiency-corrected ΔΔCt method; t test,
 *  p < 0.05,  * *  p < 0.01. 
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No changes were detected for  Mct8 mRNA levels, and 
 Oatp1a1 levels were marginally decreased with aging 
( fig. 2 ).
 Effect of Chronic Hyperthyroidism on TH Transporter 
Expression in Liver of Young and Old Mice 
 In the hyperthyroid state, similar changes in the pat-
tern of TH transporter mRNA expression in liver were 
observed for young and old mice ( fig. 3 ). T 4 treatment led 
to marked downregulation of  Oatp1a1 mRNA levels 
(0.06-fold; p < 0.001 in young and p < 0.0001 in old mice) 
and significant upregulation of  Lat1 expression (3-fold in 
young, 2.2-fold in old mice; p < 0.01). Furthermore, up-
regulation was found for  Mct10 (1.5-fold and significant 
in old mice; p < 0.05) and downregulation was observed 
for  Mct8 (0.7-fold and significant in old mice; p < 0.05) 
and  Oatp1a4 mRNA (0.6-fold and significant in old mice; 
p < 0.05) in the hyperthyroid state. Downregulation of 
 Oatp1b2 mRNA expression was observed in both age 
groups after T 4 treatment [0.59-fold in young (p < 0.05) 
and 0.46-fold in old (p < 0.0001) mice]. 
 Effect of Chronic Hyperthyroidism on TH Responsive 
Gene Expression in Liver of Young and Old Mice 
 To examine TH status in liver under chronic T 4 excess, 
mRNA transcription levels of genes proposed to respond 
to TH, namely  Spot14 (thyroid hormone-responsive 
Spot14 homolog, Thrsp),  Tbg (TH-binding globulin) and 
 Dio1 (deiodinase 1), were assessed in young and old mice 
after T 4 treatment over 7 weeks  [8, 9] .  Spot14 showed the 
smallest variations with regard to mRNA levels with up-
regulation of 1.5-fold under T 4 treatment in young (p < 
0.01) and old (p < 0.05) mice. In both age groups,  Dio1 
was highly expressed in the hyperthyroid state (10-fold 
increase; p < 0.0001) while  Tbg expression was downreg-
ulated to very low levels in young and old mice (p < 
0.0001;  fig. 4 ).
 Discussion  
 We examined changes of TH transporter expression 
during aging in a euthyroid as well as a hyperthyroid state 
in the TH target organ liver. T 4 treatment was chosen as 
the preferred TH for induction of hyperthyroidism since 
T 4 has been the most widely used iodothyronine in (hy-
perthyroid) animal experiments, allows for the assess-
ment of T 4 to T 3 conversion in a living organism and is 
standard in patients requiring TH substitution. 
 To assess the effects of chronic T 4 exposure and aging 
on TH serum status, TH serum parameters were deter-
mined in euthyroid controls and T 4 -treated animals. We 
could confirm significantly lower fT 4 concentrations in 
old male mice (20 months) compared to young male 
(4 months) mice. A decline in fT 4 values has been report-
ed in male mice during development from 2 to 20 weeks 
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 Fig. 3. Impact of hyperthyroidism on TH transporter mRNA ex-
pression in liver tissues of young and old male mice. Gene expres-
sion levels were measured by quantitative real-time PCR in liver 
tissues of T 4 -treated (1 μg/g BW T 4 i.p. every 48 h over 7 weeks) 
young (5.8 months) ( a ) and old (21.8 months) ( b ) mice, and were 
normalized to expression levels of euthyroid (PBS-treated) age-
matched controls.  a  Lat1 mRNA expression was significantly up-
regulated, whereas  Oatp1a1 and  Oatp1b2 mRNA expression levels 
were significantly decreased in liver tissues of T 4 -treated young 
mice compared to controls.  b  Mct10 and  Lat1  mRNA expression 
levels were significantly increased, whereas  Mct8 ,  Oatp1a1,
Oatp1b2 and  Oatp1a4 mRNA expression levels were significantly 
decreased in liver tissues of T 4 -treated old mice compared to con-
trols.  18S ,  Ppia and Rpl13a were used as reference genes. Data are 
presented as fold changes, means ± SEM; n = 7; efficiency-correct-
ed ΔΔCt method; t test,  *   p < 0.05,  * *   p < 0.01,  * * *   p < 0.001,
 #  p < 0.0001. 
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 [10] . Decreasing fT 4 concentrations were also noted in 
aging men  [11] . Under T 4 treatment, TT 4 , fT 4 and fT 3 
concentrations increased in young and old mice to com-
parable values. Investigation of gene expression in liver 
tissue confirmed a hyperthyroid tissue state after T 4 treat-
ment with the expected changes in the expression of the 
positively TH-regulated genes  Dio1 and  Spot14  [8] and 
the negatively regulated gene  Tbg  [9] . Further analysis of 
liver tissue with regard to TH transporters showed that 
hyperthyroidism led to a decrease in expression of the 
best-studied TH transporter  Mct8  [12, 13] and an upreg-
ulation of  Mct10 . This was seen in young and old animals, 
and could represent a compensatory reaction.  Mct8 has 
been reported to have a greater impact on TH efflux than 
influx in liver cells, as  Mct8 –/y mice have higher T 3 content 
in liver and show upregulated  Dio1 expression and activ-
ity  [14–16] . Similarly  Mct10 has been proposed to medi-
ate TH efflux in liver tissue  [16] . However, in our study 
the extent of regulation of both transporters remained in 
a significant range in livers of old mice only.
 Oatp1a1  [17] ,  Oatp1b2  [18] and  Oatp1a4  [19] were 
downregulated in a comparable fashion in hyperthyroid 
young and old mice, with marked downregulation found 
for  Oatp1a1 . As secondary TH transporters, they mainly 
transport organic compounds, amino acids and hor-
mones  [13, 20] . Therefore, their lower expression levels 
might result in lower levels of amino acids available for 
protein synthesis in hepatocytes  [21] . In contrast,  Lat1 
and  Lat2 were upregulated to high levels and in a signifi-
cant manner. Because  Lat1 is known to be highly ex-
pressed in hepatocytes under limited amino acid avail-
ability, these results are in line with the observed down-
regulation of  Oatp s. The  Lat1 response is believed to 
explain how hepatocytes can still grow under limiting 
amino acid availability, and thus acquire a survival ad-
vantage  [22, 23] . While  Lat1 prefers large neutral amino 
acids,  Lat2 has a broader specificity mediating transport 
of small neutral amino acids as well  [24] . Thus an upreg-
ulation of  Lat2 might reflect the liver’s need for small ami-
no acids.  NTCp as a multispecific organic anion trans-
porter  [13] remained unaltered during hyperthyroidism. 
 The most surprising finding of our observation is per-
haps the upregulation of most investigated TH trans-
porters with aging. This effect was seen in euthyroid and 
hyperthyroid old animals, suggesting that the liver may 
react similarly to TH excess in young and old age, at least 
at the TH transporter level. This is also in agreement with 
the observed age-independent effect of T 4 on TH-re-
sponsive genes  Spot14 ,  Dio1 and  Tbg in the liver of hy-
perthyroid old and young mice. Age-independent ex-
pression levels of  Mct8 may underline its importance in 
maintaining TH transport across the hepatocyte plasma 
membrane in TH-challenging conditions. Finally, our 
findings suggest a response to increased needs for amino 
acids and hormones in aging hepatocytes through the 
upregulation of, for example,  Lat1 and other secondary 
TH transporters like  Lat2 . Presently our findings rely on 
mRNA expression studies and it is unknown whether 
0
a
0.4
0.2
1.0
3.0
6.0
10
20
30
Fo
ld
 c
ha
ng
e 
in
 
yo
un
g 
liv
er
(h
yp
er
th
yr
oi
d/
eu
th
yr
oi
d)
Di
o1
#
Tb
g
#
**
Sp
ot1
4
0
b
0.4
0.2
1.0
3.0
6.0
10
20
30
Fo
ld
 c
ha
ng
e 
in
 
ol
d 
liv
er
(h
yp
er
th
yr
oi
d/
eu
th
yr
oi
d)
Di
o1
#
Tb
g
#
*
Sp
ot1
4
 Fig. 4. Impact of T 4 treatment on expression of TH-responsive 
genes in liver tissues of young and old male mice. Gene expression 
levels of  Dio1, Spot14 and  Tbg were measured by quantitative real-
time PCR in liver tissues of T 4 -treated (1 μg/g BW T 4 i.p. every
48 h over 7 weeks) young (5.8 months) ( a ) and old (21.8 months) 
( b ) mice, and were normalized to expression levels of euthyroid 
(PBS-treated) age-matched controls.  Dio1 and  Spot14 mRNA ex-
pression levels were significantly upregulated, whereas  Tbg  mRNA 
expression was significantly and marked downregulated in liver 
tissues of T 4 -treated young and old mice compared to controls. 
 18S ,  Ppia and Rpl13a were used as reference genes. Data are pre-
sented as fold changes, means ± SEM; n = 7; efficiency-corrected 
ΔΔCt method; t test,  *  p < 0.05,  * *  p < 0.01,  #  p < 0.0001. 
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they are representative for functional protein in the liver. 
However, with lack of specific antibodies for many TH 
transporters analyzed in this study, this issue is techni-
cally difficult to resolve in a comprehensive manner at 
this point. 
 In summary, we report changes in TH transporter 
mRNA expression in liver as a classical TH target organ 
in response to TH excess but also aging, whereby the first 
effect pertained in young and old age.
 Acknowledgements 
 The authors are grateful to A. Jaeger, S. Rehn and M. Rehders 
for their dedicated technical support. This work was supported by 
DFG FU 356/7-1, BR 1308/11-1, MO 1018/2-1.
 Disclosure Statement 
 The authors state that no conflict of interest exists.
 
 References 
 1 Cooper DS: Hyperthyroidism. Lancet 2003; 
 362: 459–468. 
 2 Franklyn JA, Sheppard MC, Maisonneuve P: 
Thyroid function and mortality in patients 
treated for hyperthyroidism. JAMA 2005; 294: 
 71–80. 
 3 Klein I, Danzi S: Thyroid disease and the 
heart. Circulation 2007; 116: 1725–1735. 
 4 Biondi B, Palmieri EA, Fazio S, Cosco C, No-
cera M, Saccà L, Filetti S, Lombardi G, Per-
ticone F: Endogenous subclinical hyperthy-
roidism affects quality of life and cardiac
morphology and function in young and mid-
dle-aged patients. J Clin Endocrinol Metab 
2000; 85: 4701–4705. 
 5 Pfaffl MW, Tichopad A, Prgomet C, Neuvians 
TP: Determination of stable housekeeping 
genes, differentially regulated target genes 
and sample integrity: BestKeeper – Excel-
based tool using pair-wise correlations. Bio-
technol Lett 2004; 26: 509–515. 
 6 Pfaffl MW, Horgan GW, Dempfle L: Relative 
expression software tool (REST) for group-
wise comparison and statistical analysis of 
relative expression results in real-time PCR. 
Nucleic Acids Res 2002; 30:e36. 
 7 Pfaffl MW: A new mathematical model for 
relative quantification in real-time RT-PCR. 
Nucleic Acids Res 2001; 29: 2002–2007. 
 8 Bianco AC, Anderson G, Forrest D, Galton 
VA, Gereben B, Kim BW, Kopp PA, Liao XH, 
Obregon MJ, Peeters RP, Refetoff S, Sharlin 
DS, Simonides WS, Weiss RE, Williams GR: 
American Thyroid Association guide to in-
vestigating thyroid hormone economy and 
action in rodent and cell models. Thyroid 
2014; 24: 88–168. 
 9 Crowe TC, Cowen NL, Loidl NM, Topliss DJ, 
Stockigt JR, Barlow JW: Down-regulation of 
thyroxine-binding globulin messenger ribo-
nucleic acid by 3,5,3 ′ -triiodothyronine in hu-
man hepatoblastoma cells. J Clin Endocrinol 
Metab 1995; 80: 2233–2237. 
 10 Weiss RE, Chassande O, Koo EK, Macchia 
PE, Cua K, Samarut J, Refetoff S: Thyroid 
function and effect of aging in combined het-
ero/homozygous mice deficient in thyroid 
hormone receptors alpha and beta genes. J 
Endocrinol 2002; 172: 177–185. 
 11 Fontes R, Coeli C, Aguiar F, Vaisman M: Ref-
erence interval of thyroid stimulating hor-
mone and free thyroxine in a reference popu-
lation over 60 years old and in very old sub-
jects (over 80 years): comparison to young 
subjects. Thyroid Res 2013; 6: 13. 
 12 Friesema EC, Ganguly S, Abdalla A, Manning 
Fox JE, Halestrap AP, Visser TJ: Identification 
of monocarboxylate transporter 8 as a specif-
ic thyroid hormone transporter. J Biol Chem 
2003; 278: 40128–40135. 
 13 Friesema EC, Jansen J, Milici C, Visser TJ: 
Thyroid hormone transporters. Vitam Horm 
2005; 70: 137–167. 
 14 Malik R, Hodgson H: The relationship be-
tween the thyroid gland and the liver. QJM 
2002; 95: 559–569. 
 15 Dumitrescu AM, Liao X-H, Weiss RE, Millen 
K, Refetoff S: Tissue-specific thyroid hor-
mone deprivation and excess in monocarbox-
ylate transporter (mct) 8-deficient mice. En-
docrinology 2006; 147: 4036–4043. 
 16 Müller J, Mayerl S, Visser T J, Darras V M, 
Boelen A, Frappart L, Mariotta L, Verrey F, 
Heuer H: Tissue-specific alterations in thy-
roid hormone homeostasis in combined 
Mct10 and Mct8 deficiency. Endocrinology 
2014; 155: 315–325. 
 17 Friesema EC, Docter R, Moerings EP, Stieger 
B, Hagenbuch B, Meier PJ, Krenning EP, 
Hennemann G, Visser TJ: Identification of 
thyroid hormone transporters. Biochem Bio-
phys Res Commun 1999; 254: 497–501. 
 18 Cattori V, Hagenbuch B, Hagenbuch N, 
Stieger B, Ha R, Winterhalter KE, Meier PJ: 
Identification of organic anion transporting 
polypeptide 4 (Oatp4) as a major full-length 
isoform of the liver-specific transporter-1 
(rlst-1) in rat liver. FEBS Lett 2000; 474: 242–
245. 
 19 Abe T, Kakyo M, Sakagami H, Tokui T, 
Nishio T, Tanemoto M, Nomura H, Hebert 
SC, Matsuno S, Kondo H, Yawo H: Molecular 
characterization and tissue distribution of a 
new organic anion transporter subtype 
(oatp3) that transports thyroid hormones and 
taurocholate and comparison with oatp2. J 
Biol Chem 1998; 273: 22395–22401. 
 20 Kinne A, Schülein R, Krause G: Primary and 
secondary thyroid hormone transporters. 
Thyroid Res 2011; 4(suppl 1):S7. 
 21 Gong L, Aranibar N, Han YH, Zhang Y, Le-
cureux L, Bhaskaran V, Khandelwal P, Klaas-
sen CD, Lehman-McKeeman LD: Character-
ization of organic anion-transporting poly-
peptide (Oatp) 1a1 and 1a4 null mice reveals 
altered transport function and urinary metab-
olomic profiles. Toxicol Sci 2011; 122: 587–
597. 
 22 Chrostowski MK, McGonnigal BG, Stabila JP, 
Padbury JF: Role of the L-amino acid trans-
porter-1 (LAT-1) in mouse trophoblast cell 
invasion. Placenta 2010; 31: 528–534. 
 23 Campbell WA, Thompson NL: Overexpres-
sion of LAT1/CD98 light chain is sufficient to 
increase system L-amino acid transport activ-
ity in mouse hepatocytes but not fibroblasts. J 
Biol Chem 2001; 276: 16877–16884. 
 24 Pochini L, Scalise M, Galluccio M, Indiveri C: 
Membrane transporters for the special amino 
acid glutamine: structure/function relation-
ships and relevance to human health. Front 
Chem 2014; 2: 1–23. 
 
